Delivery Order SPE2DB20D1004-SPE2DB24FF9Q1
Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $4.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The $2,003.28 firm fixed-price delivery order was awarded on May 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 22, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,471,651 units of the prescription drug VYVANSE 30 MG CAPSULE. The order has a total potential value of $2,373.57 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,565,135,096 units of the prescription drug VYVANSE 70 MG CAPSULE 100S. The $4,974.33 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 12, 2024 with a completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, does not have a set-aside designation for this contract. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of 4564886147 VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product. The $1,155.29 delivery order contract has a completion date of June 10, 2024 and was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that provides logistics and acquisition support to the U.S. Department of Defense. This award is under a larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,504.94 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,740 units of 40mg VYVANSE capsules. The award, which does not have a set-aside designation, has an ultimate completion date of May 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,885,067 units of the pharmaceutical product VYVANSE 50 MG CAPSULE 100S. The contract, valued at $2,608.72, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,618,549 units of the prescription medication VYVANSE 30 MG CAPSULE. The order, valued at $6,488.84, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,677.39 and an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $6,166.40, is for the delivery of 20 mg capsules of the drug VYVANSE. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA,...